IsoCode Single-Cell Adaptive Immune: Human CAR-T Protocol Using AF647-Conjugated Antibodies to CD4 and CD8

We're excited to announce the combination of Berkeley Lights and IsoPlexis, bringing together the Beacon and IsoSpark platforms to form the premier functional cell biology company. Visit Site

Protocol

IsoCode Single-Cell Adaptive Immune: Human CAR-T Protocol Using AF647-Conjugated Antibodies to CD4 and CD8

Ensure you achieve the maximum benefit from our systems and generate useful data ASAP that relates to in vivo immune activity.

Your data is secure

We keep your personal information safe and do not share it with any third parties. By submitting this form, you agree to receive communications from IsoPlexis and accept our Privacy Policy. You may unsubscribe at any time.

What's Inside

In this Protocol we discuss:

Overview

Before getting started

Protocol steps

Protocol_Human-CAR-T-Using-AF647-Conjugated-Antibodies_IsoPlexis-1

Protocol_Human-CAR-T-Using-AF647-Conjugated-Antibodies_IsoPlexis-2

Protocol_Human-CAR-T-Using-AF647-Conjugated-Antibodies_IsoPlexis-3

Protocol_Human-CAR-T-Using-AF647-Conjugated-Antibodies_IsoPlexis-4

Get the Protocol

Back to the Top